In another incredibly surprising move, the FDA ref

In another incredibly surprising move, the FDA refuses to approve a cheap generic drug that appears to reduce hospitalizations and severe illness from COVID. No one stands to make money from it, so.....

https://www.statnews.com/2022/05/16/fda-rejec...-152820318

If you read the article, and also remember that Merck's expensive anti-viral is only 30% effective yet got approved despite causing actual harm to many people.....
oh well, I know I'm preaching to the choir here.